Verition Fund Management’s AdaptHealth AHCO Stock Holding History

Verition Fund Management’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,000	Closed	-$734K	–	2687
2021 Q4	$734K	Buy	+30,000	New	+$704K	0.01%	1487

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Verition Fund Management's AHCO Position: Q1 2026 in Review

Verition Fund Management sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 18,106 shares — an estimated $180K sold.

Verition Fund Management first reported a position in AHCO in Q3 2019 and held it in 10 quarters. The position peaked at $4.25M in Q1 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

Verition Fund Management reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
Verition Fund Management sold 18,106 AdaptHealth shares in Q1 2026, an estimated $180K.
Verition Fund Management first reported a position in AdaptHealth in Q3 2019 and held it in 10 quarters.
Verition Fund Management's AdaptHealth position peaked at $4.25M in Q1 2022.
241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.